A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Public ClinicalTrials.gov record NCT07415031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Solid Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Parent Studies Investigating Adagrasib (BMS-986503)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label, solid tumor, continuation, rollover trial which enrolls participants from ongoing BMS parent studies that evaluated adagrasib (MRTX849, BMS-986503) either as monotherapy or in combination with other cancer therapies in patients with non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and other advanced solid tumors.
Study identification
- NCT ID
- NCT07415031
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 170 participants
Conditions and interventions
Conditions
Interventions
- Adagrasib Drug
- Pembrolizumab Drug
- Cetuximab Drug
- Pemetrexed Drug
- Docetaxel Drug
- Irinotecan Drug
- Leucovorin Drug
- Oxaliplatin Drug
- Fluorouracil Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 6, 2026 (Actual)
- Primary completion
- Feb 16, 2028 (Estimated)
- Completion
- Feb 16, 2028 (Estimated)
- Last update posted
- Oct 27, 2026
2026 – 2028
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0005 | Phoenix | Arizona | 85054 | Withdrawn |
| Southern California Permanente Medical Group | Bellflower | California | 90706 | Recruiting |
| MemorialCare - Long Beach Medical Center | Long Beach | California | 90806 | Recruiting |
| Local Institution - 0003 | Newark | Delaware | 19713 | Withdrawn |
| Florida Cancer Specialists - North | St. Petersburg | Florida | 33701 | Recruiting |
| Cancer Center of Kansas | Wichita | Kansas | 67208 | Recruiting |
| Local Institution - 0092 | Boston | Massachusetts | 00215 | Withdrawn |
| Local Institution - 0080 | Boston | Massachusetts | 02215 | Active, not recruiting |
| Mayo Clinic in Rochester, Minnesota | Rochester | Minnesota | 55905 | Recruiting |
| Metro-Minnesota Community Oncology Research Consortium (MMCORC) | Saint Paul | Minnesota | 55101 | Recruiting |
| Nebraska Cancer Specialists | Omaha | Nebraska | 68114 | Recruiting |
| Oncology Associates Of Oregon, Pc | Eugene | Oregon | 97401 | Recruiting |
| The West Clinic, PLLC dba West Cancer Center | Germantown | Tennessee | 38138 | Recruiting |
| Texas Oncology-Bedford | Bedford | Texas | 76022 | Recruiting |
| Texas Oncology - Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | Recruiting |
| Texas Oncology - DFW | Grapevine | Texas | 76051 | Recruiting |
| PeaceHealth St. Joseph Medical Center | Bellingham | Washington | 98225 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 83 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07415031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2026 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07415031 live on ClinicalTrials.gov.